Clinical and therapeutic implications of follistatin in solid tumours
L Shi, J Resaul, S Owen, L Ye… - Cancer genomics & …, 2016 - cgp.iiarjournals.org
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
Clinical and Therapeutic Implications of Follistatin in Solid Tumours.
L Shi, J Resaul, S Owen, L Ye… - Cancer Genomics & …, 2016 - europepmc.org
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
[PDF][PDF] Clinical and Therapeutic Implications of Follistatin in Solid Tumours
LEI SHI, J RESAUL, S OWEN, LIN YE… - CANCER GENOMICS …, 2016 - cgp.iiarjournals.org
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
Clinical and Therapeutic Implications of Follistatin in Solid Tumours
L Shi, J Resaul, S Owen, L Ye… - Cancer genomics & …, 2016 - pubmed.ncbi.nlm.nih.gov
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
Clinical and therapeutic implications of follistatin in solid tumours
L Shi, J Resaul, S Owen, L Ye… - Cancer Genomics and …, 2016 - orca.cardiff.ac.uk
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
[HTML][HTML] Clinical and Therapeutic Implications of Follistatin in Solid Tumours
LEI SHI, J RESAUL, S OWEN, LIN YE… - Cancer Genomics & …, 2016 - ncbi.nlm.nih.gov
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
Clinical and Therapeutic Implications of Follistatin in Solid Tumours.
L Shi, J Resaul, S Owen, L Ye… - Cancer Genomics & …, 2016 - europepmc.org
Follistatin (FST), as a single-chain glycosylated protein, has two major isoforms, FST288 and
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …
FST315. The FST315 isoform is the predominant form whilst the FST288 variant accounts for …